News
Is DPRO Stock a Buy, Hold or Sell After a 180.2% One-Year Surge?
Draganfly’s DPRO shares have risen 180.2% over the past year, outperforming the Zacks Aerospace-Defense industry’s growth of 7.7%. The company is capitalizing on growing demand for its drone
Intuitive Surgical Trades Near 2-Year Low: Is $600 Within Reach?
Intuitive Surgical ISRG is currently trading at a technically important juncture. After reaching an all-time high of $616 in January 2025, the stock has repeatedly retreated toward the $430 level
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
The United States is undergoing a demographic transformation of historic proportions. According to the latest data from the U.S. Census Bureau, the "Silver Tsunami" has officially arrived, with the
Semiconductor Stocks Are Booming and It's Not Just AI
The semiconductor sector is on fire. The leading semiconductor Indexes and ETFs have surged to new highs, leading the powerful market move over the last six weeks. The usual suspects, Nvidia,
PPI Sees Wholesale Inflation Shoot Up to +6.0%
Wednesday, May 13th, 2026Pre-market futures are off their early-morning highs at this hour, but early-bird investors are doing their best to parse the latest inflation report out this morning. The
CION Investment in 2026: Deal Flow Improves, Spreads Stay Compressed
CION Investment Corp. CION is moving through 2026 in a private-credit market that is active, but not easy. Competition is keeping spreads tight at the same time leverage is rising and lender
CION Investment Portfolio Mix: What It Owns and Why It Matters
CION Investment Corp. CION is built to deliver current income with modest capital appreciation, and the portfolio’s structure tells you how management is trying to get there. The company leans hard
Is CION Investment a High-Yield Value Play or a Value Trap at 0.52 P/B?
CION Investment Corp. CION is trading at a deep discount to what investors typically pay for private-credit cash flows and net asset value. The setup is hard to ignore after a steep selloff, but the
CVX's Strong Q1 Output Growth Sparks Optimism: Is It a Buy Now?
Chevron Corporation CVX has regained momentum in 2026 as investors increasingly focus on its improving long-term growth outlook, strong shareholder-return strategy and expanding exposure to
PR Q1 Earnings Beat Estimates on Strong Output, Revenues Miss
Permian Resources Corporation PR reported first-quarter 2026 adjusted earnings of 39 cents per share, beating the Zacks Consensus Estimate of 38 cents by 3%. This outperformance was primarily driven
Applied Optoelectronics Eyes 800G Ramp as Data Center Demand Tops Capacity Into 2027
Applied Optoelectronics (NASDAQ:AAOI) expects a sharp second-half ramp in its data center optics business as demand for higher-speed
Compass Pathways Q1 Earnings Call Highlights
Compass Pathways (NASDAQ:CMPS) said it has begun a rolling New Drug Application submission for COMP360, its investigational
Brainsway Q1 Earnings Call Highlights
Brainsway (NASDAQ:BWAY) reported a strong start to 2026, with first-quarter revenue rising 35% year over year as the company expanded placements of its Deep TMS systems and continued to build its
Bilfinger Q1 Earnings Call Highlights
Bilfinger (ETR:GBF) confirmed its 2026 outlook after reporting a slower start to the year, with management pointing to severe winter weather and geopolitical uncertainty as factors that delayed
Altimmune Q1 Earnings Call Highlights
Altimmune (NASDAQ:ALT) said it has strengthened its balance sheet and is preparing to begin a global Phase 3 trial of pemvidutide in metabolic
Abeona Therapeutics Q1 Earnings Call Highlights
Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center
Merck KGaA Q1 Earnings Call Highlights
Merck KGaA (ETR:MRK) reported what executives described as a “solid start” to 2026, with organic growth in its Life Science and Electronics businesses offsetting a decline in Healthcare, and raised
Deutsche Telekom Q1 Earnings Call Highlights
Deutsche Telekom (ETR:DTE) reported what Chief Executive Tim Höttges called a “robust” start to 2026, citing broad-based growth
Brenntag Q1 Earnings Call Highlights
Brenntag (ETR:BNR) said its first-quarter 2026 results reflected a slow start to the year followed by a sharp improvement in March as volatility tied to the crisis in the Middle East lifted pricing
Humacyte Q1 Earnings Call Highlights
Humacyte (NASDAQ:HUMA) reported first-quarter 2026 Symvess sales of $0.5 million and outlined a series of commercial, clinical and cost-reduction initiatives aimed at accelerating adoption of its
Atour Lifestyle Q1 Earnings Call Highlights
Atour Lifestyle (NASDAQ:ATAT) reported sharply higher first-quarter revenue for 2026, driven by continued expansion of its hotel
RWE Aktiengesellschaft Q1 Earnings Call Highlights
RWE Aktiengesellschaft (ETR:RWE) reported a stronger first quarter for fiscal 2026, with Chief Financial Officer Michael Müller telling analysts that the company had a “good start” to the year and
MLP Q1 Earnings Call Highlights
MLP (ETR:MLP) reported record first-quarter revenue and earnings for 2026, with Chief Financial Officer Reinhard Loose saying the financial services group remained on its medium-term growth path
Analysts Estimate Urban Outfitters (URBN) to Report a Decline in Earnings: What to Look Out for
Urban Outfitters (URBN) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus outlook
Star Bulk Carriers (SBLK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Star Bulk Carriers (SBLK) reports results for the quarter ended March 2026. While this widely-known consensus